Functional properties and sensory testing of whey protein concentrate sweetened with rebaudioside A

Authors

  • Paula Gimenez MILANI Universidade Estadual de Maringá
  • Antonio Sérgio DACOME Universidade Estadual de Maringá
  • Cândyce Camile Fortuna NALESSO Universidade Estadual de Maringá
  • Cássia Almeida FIORENTI Universidade Estadual de Maringá
  • Cecília Edna Mareze da COSTA Universidade Estadual de Maringá
  • Silvio Claudio da COSTA Universidade Estadual de Maringá

Keywords:

Diabetes Mellitus, Rebaudioside A, Whey protein concentrate

Abstract

Objective
To develop a natural dietary product with functional benefits for diabetic patients. Whey protein concentrate
was obtained through the separation membrane processes and sweetened with rebaudioside A. This product
was submitted to sensory testing in humans and used to evaluate possible functional properties in male Wistar
rats models with diabetes Mellitus induced by streptozotocin.
Methods
Two concentrates were produced. Only the second showed protein content of 74.3 and 17.3% of lactose was
used as supplementation in induced diabetic rats. This concentrate was obtained from the concentration by
reverse osmosis system (180 k Daltons), followed by nanofiltration in a 500 k Daltons membrane and spray
drying at 5.0% solution of the first concentrate developed. The concentrate was sweetened with rebaudioside
A (rebaudioside A 26 mg/100 g concentrate). All procedures were performed at the Center for Studies in
Natural Products, at the Universidade Estadual de Maringá. Three experimental groups were established (n=6):two groups of diabetic animals, one control group and one supplemented group; and a control group of
normal mice (non-diabetic). The supplemented group received concentrates sweetened with rebaudioside A in
a dose of 100 mg/kg bw/day by an esophageal tube for 35 days. Fasting, the fed state and body weight were
assessed weekly for all groups. At the end of the supplementation period, the following were analyzed: plasma
parameters of glucose, total cholesterol, triglycerides and fructosamine; the serum levels of aspartate
aminotransferase and alanine aminotransferase, water and food intake. Organs and tissues were removed and
weighed to assess mass and anatomical changes.
Results
The product presented 74% of proteins and 17% of lactose and showed satisfactory sensory testing by the
addition of 26 mg of rebaudioside A/100 g concentrate. Supplementation of the product reduced hyperglycemia,
plasma fructosamine levels, triglycerides and total cholesterol, and improved body weight gain of streptozotocininduced diabetic rats.
Conclusion
Whey protein concentrate with substantial content of protein (above 70%) and low lactose was obtained
through the membrane separation processes. The addition of rebaudioside A at the concentration of 26 mg/100 g
rebaudioside A proved to be as sweet as sucralose with satisfactory sensory testing, which indicates that this is
a non-caloric natural sweetener that can replace artificial sweeteners. The product (whey protein concentrate
sweetened with rebaudioside A) presented important functional properties and reduced the metabolic disorders
caused by the syndrome.

References

Pagno CH, Baldasso C, Tessaro IC, Flores SH, Jong EV. Obtenção de concentrados protéicos de soro de leite e caracterização de suas propriedades funcionais tecnológicas. Alim Nutr. 2009; 20(2):231-9.

Haraguchi FK, Pedrosa ML, Paula H, Santos RC, Silva ME. Influência das proteínas do soro sobre enzimas hepáticas, perfil lipídico e formação óssea de ratos hipercolesterolêmicos. Rev Nutr. 2009; 22(4):517-25. http://dx.doi.org/10.1590/S1415-52732009000 400007

Sgarbieri VC. Propriedades fisiológicas: funcionais das proteínas do soro do leite. Rev Nutr. 2004; 17(4):397-409. http://dx.doi.org/10.1590/S1415-52 732004000400001

Jakubowicz D, Froy O. Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and Type 2 diabetes. J Nutr Biochem. 2013; 24(1):1-5.

Mortensen LS, Jensen JH, Hartvigsen ML, Jensen VK, Astrup A, Vrese M, et al. Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes. Eur J Clin Nutr. 2012; 66:709-805.

Scherer R, Godoy HT. Antioxidant Activity Index (AAI) by 2,2-diphenyl-1-picrylhydrazyl method. Food Chem. 2009; 112(3):654-8.

Pacheco MTB, Dias NFG, Baldini VLS, Tanikawa C, Sgarbieri VC. Propriedades funcionais de hidrolisados obtidos a partir de concentrados proteicos de soro de leite. Ciênc Tecnol Aliment. 2005; 25(2):333-8.

Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005; 82(1):69-75.

Badr G, Mohany M, Metwalli A. Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice. Lipids Health Dis. 2011; 10:203-11.

Badr G, Badr MB, Mahmound MH, Mohamed M, Rabah DM, Garraud O. Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1α, MIP-2, KC, CX3CL1 and TGF-βin wounded tissue. BMC Immunol. 2012; 13:32-40.

Ebaid H, Amir SA, Sayed A, Metwalli A. Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats. Lipids Health Dis. 2011; 10:235-45.

Baldasso C, Barros TC, Tessaro IC. Concentration and purification of whey proteins by ultrafiltration. Desalination. 2011; 278:381-6.

Dacome AS, Silva CC, Costa CEM, Fontana JD, Adelmann J, Costa SC. Sweet diterpenic glycosides balance of a new cultivar of Stevia rebaudiana (Bert.) Bertoni: Isolation and quantitative distribution by chromatographic, spectroscopic, and eletrophoretic methods. Process Biochem. 2005; 40(11):3587-94.

Carakostas MC, Curry LL, Boileau AC, Brusick DJ. Overview: The history, technical function and safety of rebaudioside A, a naturally occurring steviol glycoside, for use in food and beverages. Food Chem Toxicol. 2008; 46(7):1-10.

Steinmetz WE, Lin A. NMR studies of the conformation of the natural sweetener rebaudioside A. Carbohyd Res. 2009; 344(18):2533-8.

Carvalho ACG, Oliveira RCG, Navacchi MFP, Costa CEM, Mantovani D, Dacome AS, et al. Evolution of the potencial use of rebaudioside-A as sweetener for diet jam. Food Sci Technol. 2013; 33(3):555-60.

Goto A, Clemente E. Influência do rebaudiosídeo A na solubilidade e no sabor do esteviosídeo. Ciênc Tecnol Aliment. 1998; 18(1):3-6.

Williams LD, Burdock GA. Genotoxicity studies on a hight-purity rebaudioside A preparation. Food Chem Toxicol. 2009; 47(8):1831-6.

Tadhani MB, Patel VH, Subhash R. In vitro antioxidant activities of Stevia rebaudiana leaves and callus. J Food Comp Anal. 2007; 20(3):323-9.

Abudula R, Matchkov VV, Jeppensen PB, Nilsson H, Aalkjær C, Hermansen K. Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: A glucose-dependent action via inhibition of ATP-sensitive K+-channels. Diabetes Obes Metab. 2008; 10(11):1074-85.

Association of Official Agriculture Chemists. Official methods of analysis of AOAC International. 16th ed. Arlington (VA): Association of Analytical Communities; 1995.

Instituto Adolfo Lutz. Normas Analíticas do Instituto Adolfo Lutz: métodos químicos e físicos para análises de alimentos. 4ª ed. São Paulo: IMESP; 2005. vol.1.

Costa SC, Costa CEM, Dacome AS, Diniz SPSS, Fer nandes LM, Lima COM, et al., inventors. Estudobiotecnológicos de Stevia rebaudiana (Bert) Bertoni, 2005, Brasil. Patente 1133/2005. 2005 maio 27.

Dutcosky SD. Análise sensorial de alimentos. 4ª ed. Curitiba: Universitária Champagnat; 2013.

Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001; 50(6):537-46.

Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest. 1969; 48(11):2129-39.

King AJF. The use of animal models in diabetes research. Br J Pharmacol. 2012; 166(3):877-94.

Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22(9):1462-70.

Cardoso JMP, Battochio JR, Cardello HMAB. Equi valência de dulçor e poder edulcorante de edulco rantes em função da temperatura de consumo em bebidas preparadas com chá-mate em pó solúvel. Ciênc Tecnol Aliment. 2004; 24(3):448-52.

Ramos OL, Pereira JO, Silva SI, Amorim MM, Fernandes JC, Lopes-da-Silva JA, et al. Effect of composition of commercial whey protein preparations upon gelation at various pH values. Food Res Int. 2012; 48(2):681-9.

Yee KWK, Wiley DE, Bao J. Whey protein concentrate production by continuous ultrafiltration: Operability under constant operating conditions. J Membrane Sci. 2007; 290(1-2):125-37.

Fang Y, Rogers S, Selomuya C, Chen XD. Functionality of milk protein concentrate: Effect of spray drying temperature. Biochem Engineering J. 2012; 62:101-5.

Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000; 43(12):1528-33.

Carvalheira JBC, Zecchin HG, Saad MJA. Vias de sinalização da insulina. Arq Bras Endocrinol Metab. 2002; 46(4):419-25.

Haragushi FK, Abreu WC, De Paula H. Proteínas do soro do leite: composição, propriedades nutricionais, aplicações no esporte e benefícios para saúde humana. Rev Nutr. 2006; 19(4):479-88. http://dx.doi.org/10.1590/S1415-5273200600040 0007

Takasaki K, Nakajima T, Ueno K, Nomoto Y, Higo K. Effects of combination treatment with dipeptidyl peptidase IV inhibitor and sulfonylurea on glucose levels in rats. J Pharmacol Sci. 2004; 95(2):291-3.

Jain SK. L-cysteine supplementation as an adjuvant therapy for type-2 diabetes. Can J Physiol Pharmacol. 2012; 90(8):1061-4.

Oliveira FCE, Volp ACP, Alfenas RC. Impact of different protein sources in the glycemic and insulinemic responses. Nutr Hosp. 2011; 26(4):669-76.

Zhang X, Beynen AC. Lowering effect of dietary milk-whey protein v. casein on plasma and liver cholesterol concentrations in rats. Br J Nutr. 1993; 70(1):139-46.

Mortensen LS, Hartvigsen ML, Brader LJ, Astrup A, Schrezenmeir J, Holst JJ, et al. Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: Comparison of whey, casein, gluten, and cod protein. Am J Clin Nutr. 2009; 90(1):41-8.

Downloads

Published

2023-03-21

How to Cite

Gimenez MILANI, P., DACOME, A. S., Fortuna NALESSO, C. C. ., Almeida FIORENTI, C. ., Mareze da COSTA, C. E. ., & Claudio da COSTA, S. . (2023). Functional properties and sensory testing of whey protein concentrate sweetened with rebaudioside A. Brazilian Journal of Nutrition, 29(1). Retrieved from https://puccampinas.emnuvens.com.br/nutricao/article/view/7965

Issue

Section

ORIGINAL ARTICLE